S'abonner

Long-Term Health-Related Quality of Life in Working-Age COVID-19 Survivors: A Cross-Sectional Study - 17/07/24

Doi : 10.1016/j.amjmed.2024.05.016 
Hiten Naik, MD, SM a, b, c, , James Wilton, MPH e, Karen C. Tran, MD, MHSc a, b, d, Naveed Zafar Janjua, MBBS, DrPH d, e, f, Adeera Levin, MD a, b, d, Wei Zhang, PhD c, d
a Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada 
b Post-COVID-19 Interdisciplinary Clinical Care Network, Provincial Health Services Authority, Vancouver, British Columbia, Canada 
c Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada 
d Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada 
e BC Centre for Disease Control, Provincial Health Services Authority, Vancouver, British Columbia, Canada 
f School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada 

Requests for reprints should be addressed to Hiten Naik, MD, SM, The University of British Columbia Clinician Investigator Program, Suite 200 City Square East Tower South, 555 W. 12th Avenue, Vancouver, BC V5Z 3X7, Canada.The University of British Columbia Clinician Investigator ProgramSuite 200 City Square East Tower South 555 W. 12th AvenueVancouverBCV5Z 3X7Canada

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 17 July 2024

Abstract

Background

Most working-age (18-64) adults have been infected with SARS-CoV-2, and some may have developed post-COVID-19 condition (PCC). However, long-term health-related quality of life (HRQOL) following infection remains uncharacterized.

Methods

In this cross-sectional study, COVID-19 survivors from throughout British Columbia (BC), Canada, completed a questionnaire >2 years after infection. PCC status was self-reported, and HRQOL was assessed using the EuroQol 5-dimension 5-level (EQ-5D-5L) instrument. We compared HRQOL in those with current PCC, those with recovered PCC, and those without a history of PCC. Multivariable analyses were weighted to be representative of COVID-19 survivors in BC.

Results

Of the 1,135 analyzed participants, 19.2% had current PCC, and 27.6% had recovered PCC. Compared to those without a history of PCC, participants with recovered PCC had a similar mean EQ-5D health utility (adjusted difference -0.02 [95%CI -0.03, 0.00]), but those with current PCC had a lower health utility (adjusted difference -0.08 [95%CI -0.12, -0.05]). Participants with current PCC were also more likely to report problems with mobility (adjusted odds ratio (aOR) 6.00 [95%CI 2.88-12.52]), self-care (aOR 5.96 [95%CI 1.84-19.32]), usual activities (aOR 8.00 [95%CI 4.27-14.99]), pain/discomfort (aOR 4.28 [95%CI 2.46-7.48]), and anxiety/depression (aOR 3.45 [95%CI 1.90-6.27]).

Conclusions

In working-age adults who have survived >2 years following COVID-19, HRQOL is high among those who never had PCC or have recovered from PCC. However, individuals with ongoing symptoms have lower HRQOL and are more likely to have functional deficits. These findings underscore the importance of implementing targeted healthcare interventions to improve HRQOL in adults with long-term PCC.

Le texte complet de cet article est disponible en PDF.

Keywords : Activities of daily living, COVID-19, Employment, Post-acute COVID-19 syndrome, SARS-CoV-2, Cross-sectional study, Health-related quality of life


Plan


 Funding: HN is supported by The University of British Columbia Clinician Investigator Program and a CAN-TAP-TALENT & Michael Smith Health Research BC Postdoctoral Fellowship. WZ has been supported by a Michael Smith Health Research BC Scholar award. This study was funded in part by the St. Paul's Foundation and British Columbia Ministry of Health.
 Conflict of Interest: HN is a member of the Canadian Guidelines for Post-COVID-19 Condition Guideline Team for Pharmacologic and Nonpharmacologic Clinical Interventions.
 Role of Funder: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.


© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.